The National Lung Screening Trial (NLST), the largest randomized lung screening trial ever conducted, showed a substantial benefit for heavy smokers aged 55-74 who were screened for lung cancer using low-dose computed tomography (LDCT) scans. CT screening identified more lung cancers at earlier stages resulting in a significant decrease (20 percent ) in lung cancer mortality in the screened group.